article thumbnail

J&J, AbbVie, Sanofi and many other companies face competition probe in Turkey

Fierce Pharma

Turkish authorities have launched an investigation into 19 pharmaceutical companies to probe whether their operations violated the country’s competition law, the Turkish Competition Authority discl | The companies, which include Pfizer, J&J, Sanofi, AbbVie, AstraZeneca, Merck and others are being probed for potentially violating Turkish competition (..)

article thumbnail

CarePoint sues RWJBarnabas over alleged care monopolization scheme

MedCity News

The complaint alleged that RWJBarnabas conspired with real estate investors, New Jersey’s largest payer and government officials to eliminate competition and monopolize acute care services in the state.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharmacogenomics: Creating a Better Healthcare System

MedCity News

While current government and commercial efforts to negotiate competitive drug prices are important, this focus represents a minor—and misplaced—implementation of medication management. It’s time that policymakers, insurers and healthcare providers make pharmacogenomic testing a fundamental standard of care delivery.

article thumbnail

Innovation key for boosting UK biopharma competitiveness

European Pharmaceutical Review

New recommendations to boost the competitiveness in UK biopharma and Medtech sectors have been published by Imperial College London. The ‘Sectoral Systems of Innovation and the UK’s Competitiveness’ reports assess the value-added per capita of each sector and how they compare internationally.

article thumbnail

FTC order could ease biopharma competition

European Pharmaceutical Review

to address the potential competitive harm Amgen’s $27.8 Consolidation in the pharmaceutical industry has given companies the power and incentive to engage in exclusionary rebating practices, which can lead to sky-rocketing prices on essential medications,” stated Henry Liu, Director of the FTC’s Bureau of Competition.

article thumbnail

UK Government to fund research into new obesity treatments

Pharmaceutical Technology

The UK Government has announced funds worth $24.17m (£20m) to conduct research for developing new obesity therapies and technologies. The latest investment by the government is anticipated to aid the NHS in saving billions over time and guarantee that crucial funds are allocated to important key frontline services.

article thumbnail

Can we get healthcare right?

World of DTC Marketing

According to The Hill “, a large majority of the public favors allowing the government to negotiate for lower prescription drug prices, according to a new poll that comes as a legislative battle plays out on the issue. Innovation and Competition Act. Government assistance programs include: U.S. Administration on Aging.